SCHEMBL6290446

SCHEMBL6290446

COc1ccc2c(CC(=O)O)c(C)[nH]c2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.80
KDM4E B2RXH2 9/20 0.60
GAA P10253 6/20 0.60
MAPT P10636 5/20 0.60
ALDH1A1 P00352 4/20 0.60
CASP1 P29466 1/20 0.60
CASP7 P55210 1/20 0.60
PTGS2 P35354 3/20 0.60
GPR17 Q13304 1/20 0.59
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
TUBB1 Q9H4B7 1/20 0.51
PTGS1 P23219 2/20 0.50
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
DRD3 P35462 1/20 0.50
PTPN5 P54829 1/20 0.49
HTR1D P28221 1/20 0.48
HTR6 P50406 1/20 0.48
MCL1 Q07820 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Deschlorobenzoyl Indomethacin SCHEMBL454792 0.89 AKR1C2 (1.00) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL7956382 0.87 AKR1C2 (0.61) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL19872632 0.86 GPR17 (0.74) AKR1C2KDM4EALDH1A1PTGS2GPR17
SCHEMBL19534913 0.84 AKR1C2 (0.57) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL6288056 0.82 KDM4E (0.77) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL4659699 0.81 AKR1C2 (0.54) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL2004066 0.81 KDM4E (0.65) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL31381374 0.79 KDM4E (0.63) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL6287665 0.79 KDM4E (0.63) AKR1C2KDM4EGAAMAPTALDH1A1
SCHEMBL11338063 0.79 AKR1C2 (0.66) AKR1C2KDM4EGAAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK AKR1C2 2816/4885KDM4E 2972/4885GAA 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.